BioElpida
Trending Articles
Related Content
Manufacturing
BioVaxys and BioElpida agree to begin ovarian cancer vaccine bioproduction
The two companies have signed the new definitive agreement focusing on the GMP facility build-out in Lyon, and technical aspects of the bioproduction protocol such as process design and validation, quality control and quality assurance steps, batch test runs, stability testing, and aseptic fill